Hypothesis-Generating Brief: Vascular age

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Populate Key Findings and each per-outcome-class subsection (Cardiometabolic, Deficiency Prevalence, Longevity, Mechanism, Safety and Comorbidity) with concrete prose that names individual cited sources (e.g., Sheng 2025 ePWV and CAD; Lu 2026 NCAA and CVD; Azizzadeh 2026 LEAD prevalence; Luo 2025 L-citrulline meta-analysis; Kakaletsis 2024 AIS meta-analysis; Alanis 2025 vascular aging clusters and troponin I) and states, for each, what finding was extracted, its direction, its effect estimate, and its directness tier.
2. Reconcile the outcome-class directional coding with the actual source bundle: for every cited source, assign it to exactly one outcome class in the Evidence Landscape table, and either (a) update the coded direction to match the extracted finding or (b) explicitly explain why a directionally positive primary study is coded 'unclear' or 'null' in the table.
3. Rewrite the Search Summary to describe the actual selection logic that maps the 43 source candidates to the 13 admitted sources using the non-additive audit buckets, and report a single transparent exclusion count with reasons rather than overlapping categories.
4. In Limitations, add a specific statement about forward-dated (2026) citations and the implications for reproducibility, and remove or relocate the AI-use disclosure so it does not crowd the substantive sections.
5. Tighten the Conclusion so that the tiered reading is grounded in named source-level findings rather than abstract classes; the current conclusion could be applied to almost any thin-corpus synthesis and does not show what was actually learned about vascular age.

Major issues

• The Key Findings and Evidence Landscape sections are structurally empty placeholders: 'Key Findings' contains only two repeated metadata notes, and the per-outcome-class subsections (Cardiometabolic, Deficiency Prevalence, Longevity, Mechanism, Safety and Comorbidity) contain no prose, no source-level findings, no integration of the 13 cited sources, and no link from each cited study to the outcome class it supports.
• The manuscript declares 12/13 sources are indirect/review/mechanistic and 7/13 have null or no extracted directional signal, yet the bundle contains multiple primary observational and RCT studies with concrete effect estimates (Sheng 2025 HR 1.50 [1.25-1.81]; Lu 2026 HR 1.21 [1.01-1.45]; Azizzadeh 2026 EVA prevalence 12.2% with ORs; Luo 2025 FMD pooled effect 1.81 [0.76-2.85]; Kakaletsis 2024 meta-analysis with n=6,006 AIS patients) that the synthesis never surfaces, integrates, or even names in prose. This is a substantial synthesis gap relative to a stated 'rapid evidence synthesis' article type.
• Search Summary states 'No records were excluded at the gates' yet the funnel shows 43 source candidates reduced to 13 admitted with multiple non-additive audit buckets ('Mixed partial-or-none' n=49, 'Partial-only' n=14, 'Strict high-confidence' n=7) that are never reconciled; the inclusion logic is not auditable from the manuscript alone.
• Outcome-class and source-context tables report 'receipt-level direction coded unclear' or 'null' across nearly every slice, but the underlying source bundle contains several clearly directional primary studies; either the coding is inconsistent with the bundle or the coding framework is not explained, undermining the tiered evidence hierarchy the conclusion rests on.

Minor issues

• Several cited years are future-dated relative to typical publication cycles (2026 entries Nguyen, Rodilla, Azizzadeh, Lu, Kozlik) and the retrieval window is 2026-06-26; while plausible for in-press articles, this should be flagged in limitations as forward-dated citations rather than silently used.
• The title is labeled 'Hypothesis-Generating Brief: Vascular age — full paper' but the article_type is 'rapid_evidence_synthesis'; the relationship between brief and full paper is not stated.
• AI-use disclosure is unusually prominent for a published-style synthesis and may distract readers from the substantive content.
• 'Outcome-class note' and 'Source-context map' headers are repeated verbatim in Key Findings, Evidence Landscape, and Search Summary, suggesting template leakage rather than deliberate emphasis.

Reviewer note

This rapid evidence synthesis on vascular age has a defensible scope statement, a reproducible-looking search protocol, and an appropriately conservative conclusion that resists clinical-efficacy overclaim. However, the manuscript is structurally incomplete as a synthesis: Key Findings is empty, the per-outcome-class subsections in Evidence Landscape contain no prose, and the 13 cited sources — several of which carry concrete, directional effect estimates (Sheng 2025 HR 1.50; Lu 2026 HR 1.21; Luo 2025 pooled FMD effect 1.81; Azizzadeh 2026 EVA prevalence 12.2%; Kakaletsis 2024 PWV meta-analysis with 6,006 AIS patients) — are never integrated or even named in the body. The outcome-class directional coding ('unclear' or 'null' across nearly every slice) is inconsistent with the bundle contents and is not explained. The funnel reporting in Search Summary uses non-additive audit buckets without reconciliation, so the inclusion logic is not auditable from the manuscript alone. Because the gaps are bounded (the bundle is small, the framework exists, and the conclusion is correctly tiered) the manuscript is salvageable with bounded edits: populate Key Findings and each outcome-class subsection with source-level prose, reconcile coding with the bundle, fix the funnel accounting, and tighten the conclusion to reflect what was actually learned. Recommendation: revise.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis